Pure Global AI
NCT06335875Recruiting

Brain Small Chain Fatty Acid Metabolism in Bipolar Disorder: Ketones

University of MichiganClinicalTrials.govdietary supplement
Verified
Study focus
Disease/Condition
Bipolar Disorder
Drug/Device/Intervention
Ketone Ester Beverage
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
University of Michigan
Location
Ann Arbor,Ann Arbor, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Mar 01, 2027
Enrollment
12 participants
Primary outcome

Change in blood beta-hydroxybutyrate level

Summary

Small exploratory open-label pilot study to assess supplementation of a ketone ester
 (Juvenescence) combined with a 'ketogenic-mimicking diet' as a potential therapy for persons
 with bipolar disorder.

ICD-10 classifications
Bipolar affective disorderBipolar affective disorder, unspecifiedOther bipolar affective disordersBipolar affective disorder, currently in remissionBipolar affective disorder, current episode mixed
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06335875
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06335875 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Bipolar Disorder. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.